Table 1 Characteristics of patients classified by VZV reactivation
| Â | All patients | Patients without VZV reactivation | Patients with VZ reactivation | P Value |
|---|---|---|---|---|
No. of patients | 219 | 169 | 50 | Â |
Patient age (y) | Â | Â | Â | 0.188 |
 Median (range) | 32 (14- 58) | 31 (14- 58) | 35.5 (16- 57) |  |
Patient sex | Â | Â | Â | 0.554 |
 Female | 82 (37.4%) | 61 (36.1%) | 21 (42.0%) |  |
 Male | 137 (62.6%) | 108 (63.9%) | 29 (58.0%) |  |
Disease type | Â | Â | Â | 0.914 |
 AML | 106 (48.4%) | 82 (48.5%) | 24 (48.0%) |  |
 ALL | 94 (42.9%) | 73 (43.2%) | 21 (42.0%) |  |
 Others* | 19 (8.68%) | 14 (8.28%) | 5 (10.0%) |  |
Disease risk index | Â | Â | Â | 0.954 |
 Low | 2 (0.91%) | 2 (1.18%) | 0 (0.00%) |  |
 Intermediate | 188 (85.8%) | 142 (84.0%) | 44 (88.0%) |  |
 High | 29 (13.2%) | 23 (13.6%) | 6 (12.0%) |  |
Donor type | Â | Â | Â | 0.389 |
 Matched related | 78 (35.6%) | 61 (36.1%) | 17 (34.0%) |  |
 Mismatched related | 124 (56.6%) | 94 (55.6%) | 30 (60.0%) |  |
 Matched unrelated | 9 (4.11%) | 6 (3.55%) | 3 (6.00%) |  |
 Mismatched unrelated | 8 (3.65%) | 8 (4.73%) | 0 (0.00%) |  |
Sex matched | Â | Â | Â | 0.276 |
 Matched | 109 (49.8%) | 88 (52.1%) | 21 (42.0%) |  |
 Mismatched | 110 (50.2%) | 81 (47.9%) | 29 (58.0%) |  |
Donor sex | Â | Â | Â | 0.341 |
 Female | 69 (31.5%) | 50 (29.6%) | 19 (38.0%) |  |
 Male | 150 (68.5%) | 119 (70.4%) | 31 (62.0%) |  |
Donor age (y) | Â | Â | Â | 0.516 |
 Median (range) | 31 (11- 62) | 30 (11- 62) | 33 (14- 60) |  |
Conditioning regimen | Â | Â | Â | 1.000 |
 NMAC | 1 (0.46%) | 1 (0.59%) | 0 (0.00%) |  |
 MAC | 214 (99.5%) | 168 (99.4%) | 50 (100%) |  |
ATG | Â | Â | Â | 0.463 |
 No | 50 (22.8%) | 41 (24.3%) | 9 (18.0%) |  |
 Yes | 169 (77.2%) | 128 (75.7%) | 41 (82.0%) |  |
DLI | Â | Â | Â | 0.870 |
 No | 189 (86.3%) | 145 (85.8%) | 44 (88.0%) |  |
 Yes | 30 (13.7%) | 22 (14.2%) | 6 (12.0%) |  |
aGvHD | Â | Â | Â | 0.850 |
 Grade: 0–1 | 123 (56.2%) | 96 (56.8%) | 27 (54.0%) |  |
 Grade: 2–4 | 96 (43.8%) | 73 (43.2%) | 23 (46.0%) |  |
cGvHD | Â | Â | Â | 0.113 |
 No | 120 (54.8%) | 98 (58.0%) | 22 (44.0%) |  |
 Yes | 99 (45.2%) | 71 (42.0%) | 28 (56.0%) |  |
CMV reactivation | Â | Â | Â | 0.285 |
 No | 91 (41.6%) | 74 (43.8%) | 17 (34.0%) |  |
 Yes | 128 (58.4%) | 95 (56.2%) | 33 (66.0%) |  |